Legal Representation
Attorney
Gregory B. Phillips
USPTO Deadlines
Next Deadline
1799 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241231)
Due Date
December 31, 2030
Grace Period Ends
June 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 31, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 31, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 12, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 12, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 23, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 3, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 3, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 3, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 3, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 3, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 5, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 28, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 19, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jan 9, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer, auto-immune diseases and infectious diseases; pharmaceutical preparations containing antibodies for the treatment of cancer, auto-immune diseases and infectious diseases; pharmaceutical preparations containing recombinant proteins for the treatment of cancer, auto-immune diseases and infectious diseases
Classification
International Classes
005